| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/12/2005 | CA2544350A1 N-substituted benzene sulfonamides |
| 05/12/2005 | CA2543918A1 Benzimidazoles useful as modulators of ion channels |
| 05/12/2005 | CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | CA2543533A1 2-cyanopyrrolidinecarboxamide compound |
| 05/12/2005 | CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv |
| 05/12/2005 | CA2543346A1 Benzimidazolyl derivatives |
| 05/12/2005 | CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| 05/12/2005 | CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 05/12/2005 | CA2487210A1 Asymmetrical linear organic oligomers |
| 05/11/2005 | EP1529530A1 Compounds affecting glucokinase |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 05/11/2005 | EP1529042A1 Arylamides |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1528924A1 Mch1r antagonists |
| 05/11/2005 | EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 05/11/2005 | EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 05/11/2005 | CN1615300A Benzimidazole derivatives and their use as GNRH antagonists |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890930 Quinazolinones |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890885 Herbicidal composition |
| 05/06/2005 | WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 05/06/2005 | WO2005040155A1 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 05/06/2005 | WO2005040151A1 Pyrazine derivatives and pharmaceutical use thereof |
| 05/06/2005 | WO2005040137A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| 05/06/2005 | WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| 05/06/2005 | WO2005040135A1 Antistress drug and medical use thereof |
| 05/06/2005 | WO2005040128A1 Heterocyclyl compounds |
| 05/06/2005 | WO2005040126A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors |
| 05/06/2005 | WO2005028443A3 Protein tyrosine kinase enzyme inhibitors |
| 05/06/2005 | WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543644A1 Pyrazine derivatives and pharmaceutical use thereof |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | CA2540765A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 05/05/2005 | US20050096363 Activator of peroxisome proliferator-activated receptor delta |
| 05/05/2005 | US20050096354 Process for the preparation of substituted aryl pyrazoles |
| 05/05/2005 | US20050096350 Halo substituted benzo[b]thiophenes as therapeutic agents |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096344 controlling signal transduction; anticancer agents; antitumor agents; angiogenesis inhibitors; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents; antiischemic agents |
| 05/05/2005 | US20050096330 N-(indolecarbonyl) piperazine derivatives |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527069A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 05/04/2005 | EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1199956C Oxadiazole derivs. having anticancer effects |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/04/2005 | CN1199947C Process for production of pyridine derive |
| 05/03/2005 | US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887831 For use as herbicides |
| 05/03/2005 | CA2320388C Novel dihydroxyhexanoic acid derivatives |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037827A1 Process for preparing benzimidazole thiophenes |
| 04/28/2005 | WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation |
| 04/28/2005 | WO2005037792A1 Derivatives of n-``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 04/28/2005 | WO2005037781A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005037199A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/28/2005 | WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 04/28/2005 | WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/28/2005 | US20050090543 Method for the preparation of tetrahydrobenzothiepines |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090501 Heteroaryl-cyclic acetals |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |